Improvements in cough-specific quality of life occurred in both groups after 2 weeks ( montelukast : mean 27 , 95 % CI 22-33 ; placebo : 36 , 29-43 ) , but the difference between groups did not meet the minimum clinically important difference of 13 ( mean difference -09 , -17 to -004 , p = 004 ) .